Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor–Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell–Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study-Reference-Cited by-同舟云学术

Impact of Single-Dose Plerixafor as an Adjunct to Granulocyte Colony-Stimulating Factor–Based Peripheral Blood Stem Cell Mobilization on the Graft Composition and Outcome for T Cell–Replete Haploidentical Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: A Comparative Study

Published:2018-03 Issue:3 Volume:24 Page:542-548
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Jaiswal Sarita Rani,Bhakuni Prakash,Joy Aby,Murli Nisha,Bharadwaj Priyanka,Zaman Shamsur,Nedunchezian Murugayan,Chakrabarti Suparno

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference29 articles.

1. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation;Luznik;Semin Oncol,2012

2. Haploidentical “megadose” CD34+ cell transplants for patients with acute leukemia;Martelli;Leukemia,2002

3. Peripheral blood hematopoietic stem cells for transplantation of hematological diseases from related, haploidentical donors after reduced-intensity conditioning;Raj;Biol Blood Marrow Transplant,2014

4. Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation;Hauge;Transfusion,2014

5. The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil);De;Biochem Pharmacol,2009

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Follow-Up of Abatacept, Post-Transplantation Cyclophosphamide, and Sirolimus-Based Haploidentical Transplantation in Younger Patients with Nonmalignant Diseases;Transplantation and Cellular Therapy;2024-06

2. Take a spin: Apheresis in the care of adult leukaemia patients;Best Practice & Research Clinical Haematology;2023-06

3. Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments;Annals of Hematology;2023-03-22

4. Efficacy and safety of a reduced dose of plerixafor in combination with granulocyte colony‐stimulating factor in healthy haploidentical stem cell donors;Vox Sanguinis;2022-03-24

5. Plerixafor use in autologous hematopoietic stem cell mobilization: Experience from a single center in Southern India;Asian Journal of Transfusion Science;2022